These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 15492270)

  • 1. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
    Zhou B; Liu L; Reddivari M; Zhang XA
    Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
    Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
    Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration.
    Zhang XA; He B; Zhou B; Liu L
    J Biol Chem; 2003 Jul; 278(29):27319-28. PubMed ID: 12738793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KAI1/CD82, a tumor metastasis suppressor.
    Liu WM; Zhang XA
    Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer.
    Lee JH; Park SR; Chay KO; Seo YW; Kook H; Ahn KY; Kim YJ; Kim KK
    Cancer Res; 2004 Jun; 64(12):4235-43. PubMed ID: 15205336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.
    Sridhar SC; Miranti CK
    Oncogene; 2006 Apr; 25(16):2367-78. PubMed ID: 16331263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation.
    Delaguillaumie A; Harriague J; Kohanna S; Bismuth G; Rubinstein E; Seigneuret M; Conjeaud H
    J Cell Sci; 2004 Oct; 117(Pt 22):5269-82. PubMed ID: 15454569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression.
    Lee JH; Seo YW; Park SR; Kim YJ; Kim KK
    Cancer Res; 2003 Nov; 63(21):7247-55. PubMed ID: 14612520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.
    Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P
    Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese.
    Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H
    Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KAI1 tetraspanin and metastasis suppressor.
    Jackson P; Marreiros A; Russell PJ
    Int J Biochem Cell Biol; 2005 Mar; 37(3):530-4. PubMed ID: 15618009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
    White A; Lamb PW; Barrett JC
    Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes.
    Mashimo T; Bandyopadhyay S; Goodarzi G; Watabe M; Pai SK; Gross SC; Watabe K
    Biochem Biophys Res Commun; 2000 Aug; 274(2):370-6. PubMed ID: 10913345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway.
    Jee B; Jin K; Hahn JH; Song HG; Lee H
    Exp Mol Med; 2003 Feb; 35(1):30-7. PubMed ID: 12642901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
    Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
    Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
    Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
    Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
    Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
    Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
    Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD82, and CD63 in thyroid cancer.
    Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C
    Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.